domingo, 9 de enero de 2022

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era - The Lancet Oncology

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era - The Lancet Oncology

No hay comentarios:

Publicar un comentario